undamentalytics Newsletter
Sign in

Inogen Inc revenue

Inogen Inc's revenue was $349m in fiscal 2025, up 3.9% on the year before. Since fiscal 2012 ($48.6m) it has grown at a compound 16.4% a year. Over the last twelve months it was $354m.

Revenue history

US$ millions unless shown otherwise. Fiscal years, plus the last twelve months (LTM) when newer.

Fiscal year2012Dec 20122013Dec 20132014Dec 20142015Dec 20152016Dec 20162017Dec 20172018Dec 20182019Dec 20192020Dec 20202021Dec 20212022Dec 20222023Dec 20232024Dec 20242025Dec 2025LTMJun 2026
Revenue4975113159203249358362308358377316336349354
Growth on the year before—+55.3%+49.2%+41.3%+27.6%+23.0%+43.6%+1.1%−14.8%+16.1%+5.4%−16.3%+6.4%+3.9%—
Gross profit2439567697121179172138176154127155154158
Gross margin49.3%51.7%49.3%48.0%48.0%48.6%49.9%47.5%44.8%49.3%40.7%40.1%46.1%44.2%44.5%

Revenue as reported in the company's 10-K and 10-Q filings (for banks, net interest income plus non-interest income). Growth is left blank when the earlier figure was zero or negative.

Where the revenue comes from

Fiscal year to December 31, 2025
Geography
Region Revenue YoY
United States $156M ▼ 3.1%
Outside the US $139M ▲ 18.4%

These categories overlap or exclude eliminations, so shares aren't shown.

From Inogen Inc's 10-K filed February 27, 2026, as tagged in the filing. View filing. Indented rows are part of the line above; their share is of that line. In the bars, the faint bar behind is the year before.

Revenue against peers

Health Care Equipment: the closest covered companies by revenue. Last twelve months.

CompanyRevenueGrowth3-year growth a year
Inogen Inc $354m 3.2% 0.5%
Tactile Systems Technology Inc $356m 14.4% 9.6%
Staar Surgical Co $340m 51.3% 9.2%
Inmode Ltd. $370m -6.2% —
Procept Biorobotics Corp $337m 22.7% 49.2%
Angiodynamics Inc $325m 8.2% -1.1%

Compare with peers

Head to head: INGN vs TCMDINGN vs STAAINGN vs INMDINGN vs PRCT

More: Health Care Equipment stocks compared, Health Care sector, rankings of US companies

Figures from Inogen Inc's SEC filings (10-K and 10-Q), retrieved October 29, 2026. How we read and check them: methodology and data sources. Not investment advice. Back to Inogen Inc.